415 related articles for article (PubMed ID: 9437559)
1. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
Potter LS; Dalberth BT; Cañamar R; Betz M
Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
[TBL] [Abstract][Full Text] [Related]
2. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
3. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
Keder LM; Rulin MC; Gruss J
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):583-5. PubMed ID: 9757955
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
5. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms and Depo-Provera.
Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
[TBL] [Abstract][Full Text] [Related]
8. Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use.
Archer B; Irwin D; Jensen K; Johnson ME; Rorie J
J Nurse Midwifery; 1997; 42(2):104-11. PubMed ID: 9107118
[TBL] [Abstract][Full Text] [Related]
9. Adolescent satisfaction with postpartum contraception and body weight concerns.
Hellerstedt WL; Story M
J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
[TBL] [Abstract][Full Text] [Related]
10. Depo Provera: a profile of current users.
Jarman H; Kovacs GT; Westcott M
Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
[TBL] [Abstract][Full Text] [Related]
11. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
Pardthaisong T; Gray RH; McDaniel EB
Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
[TBL] [Abstract][Full Text] [Related]
12. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
13. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
14. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
15. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
16. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
17. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
[TBL] [Abstract][Full Text] [Related]
18. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
19. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
20. DMPA use above the age of 35 in Thai women.
Taneepanichskul S; Reinprayoon D; Phaosavadi S
Contraception; 2000 Apr; 61(4):281-2. PubMed ID: 10899485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
